Severe pulmonary toxicity in a patient treated with gemcitabine

Manuel F. Rosado, Daniel H. Kett, Roland M.H. Schein, Francisco J. Baraona, Kasi S. Sridhar

Research output: Contribution to journalArticlepeer-review

26 Scopus citations


Gemcitabine is a pyrimidine analog of deoxycytidine with activity against nonhematologic and hematologic malignancies. Its pulmonary toxicity is usually mild and self-limiting. We describe a male patient with lung cancer in whom severe dyspnea and interstitial infiltrates developed after the administration of gemcitabine.

Original languageEnglish (US)
Pages (from-to)31-33
Number of pages3
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Issue number1
StatePublished - 2002


  • Gemcitabine
  • Pulmonary toxicity

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Severe pulmonary toxicity in a patient treated with gemcitabine'. Together they form a unique fingerprint.

Cite this